Rice Hall James & Associates’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
76,287
-285
| -0.4% | -$9.01K | 0.13% | 149 |
|
|
2025
Q1 | $2.54M | Sell |
76,572
-178
| -0.2% | -$5.91K | 0.15% | 139 |
|
|
2024
Q4 | $2.64M | Sell |
76,750
-2,521
| -3% | -$86.7K | 0.15% | 153 |
|
|
2024
Q3 | $3.17M | Sell |
79,271
-1,241
| -2% | -$49.6K | 0.17% | 134 |
|
|
2024
Q2 | $2.43M | Buy |
80,512
+23,867
| +42% | +$720K | 0.15% | 145 |
|
|
2024
Q1 | $1.9M | Sell |
56,645
-10,709
| -16% | -$360K | 0.11% | 178 |
|
|
2023
Q4 | $2.18M | Sell |
67,354
-33,740
| -33% | -$1.09M | 0.13% | 165 |
|
|
2023
Q3 | $3.31M | Sell |
101,094
-1,456
| -1% | -$47.7K | 0.21% | 112 |
|
|
2023
Q2 | $3.61M | Sell |
102,550
-17,942
| -15% | -$631K | 0.2% | 114 |
|
|
2023
Q1 | $3.93M | Buy |
120,492
+38,174
| +46% | +$1.25M | 0.22% | 109 |
|
|
2022
Q4 | $4.54M | Sell |
82,318
-23,809
| -22% | -$1.31M | 0.26% | 91 |
|
|
2022
Q3 | $4.7M | Sell |
106,127
-1,411
| -1% | -$62.5K | 0.27% | 91 |
|
|
2022
Q2 | $5.25M | Sell |
107,538
-16,144
| -13% | -$787K | 0.25% | 82 |
|
|
2022
Q1 | $6.02M | Sell |
123,682
-13,964
| -10% | -$679K | 0.24% | 84 |
|
|
2021
Q4 | $5.87M | Sell |
137,646
-1,568
| -1% | -$66.9K | 0.21% | 94 |
|
|
2021
Q3 | $5.34M | Sell |
139,214
-1,224
| -0.9% | -$46.9K | 0.2% | 91 |
|
|
2021
Q2 | $3.97M | Sell |
140,438
-6,467
| -4% | -$183K | 0.14% | 109 |
|
|
2021
Q1 | $4.85M | Buy |
146,905
+112,630
| +329% | +$3.72M | 0.16% | 116 |
|
|
2020
Q4 | $1.24M | Buy |
+34,275
| New | +$1.24M | 0.04% | 237 |
|